CROI 2020 e-Newsletter




CROI 2020 2_web newletter_button



About the Program:

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 27th Conference on Retroviruses and Opportunistic Infections (CROI 2020). This program consists of four components: (1) From Conference to Clinic: Reviewing and Applying Data from CROI 2020: a case-based on-line webcast featuring expert faculty reviewing key presentations with a focus on clinical management and treatment; (2) CME Internet Symposium*: CROI 2020 Expert Review: a 1.5-hour Internet symposium that features an overview of key presentations and posters, selected by the expert faculty; (3) Rapid-Fire Review of CROI 2020*: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (4) CROI 2020 e-Newsletter: a brief on-line summary of the most essential data presented at the conference.

The CROI 2020 e-Newsletter features a portable electronic summary of key presentations and data presented at the conference. This activity will quickly enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care.  

This program is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. It is not a session created by or presented at CROI 2020 and it is not sanctioned by the organizers of CROI 2020. 

** This component is jointly provided by the Postgraduate Institute for Medicine and ViralEd, Inc and supported by an independent educational grant from Gilead Sciences Medical Affairs. 

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Learning Objectives:

After completing this activity, the participant should be better able to:

  • Explain the epidemiology of HIV today
  • Initiate ARV therapy rapidly following an HIV diagnosis
  • Select optimal ARV therapy to all people with HIV infection
  • Identify the risk and causes of ARV resistance and learn how to reduce this risk through appropriate ARV regimen selection
  • Assess the impact of ARV adverse events on treatment success and be able to adjust ARV regimens to maximize tolerability
  • Recognize ARV adverse effects, especially neuropsychiatric effects and weight gain,and adjust ARV regimens to minimize these effects
  • Recognize mental health issues, such as stress, anxiety, depression, and substance use, in patients being treated for HIV infection, and employ approaches for addressing these mental health issues

Release Date: April 3, 2020

Expiration Date: April 3, 2021

Estimated time to complete the program: 30 minutes

Type of hardware/softward needed to participate in activity: PC/Mac/tablet/smartphone with internet browser

Back to Top


Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the accredtation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing education for the healthcare team. 

Credit Designation:

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest:

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to The Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Renslow Sherer, MD

  • Nothing to Disclose

Annenberg Center for the Health Sciences at Eisenhower staff involved in this activity have no relevant commercial relationships to disclose.

The PIM planners and managers have nothing to disclose.

The ViralEd planners and managers have nothing to disclose. 

Back to Top

Instructions for Participation and Credit:

There are no fees for participating and receiving CME credit for this activity.  During the period, April 3, 2020 through April 3, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment of completing this activity, please complete the evaluation on On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 15286.  Upon registering and successfully completing the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top


PIM_small          Annenberg Center For Health Science logo

VE logo 300px


This activity is supported by an independent educational grant from Janssen Therapeutics.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

Prepare to print

Share this page:

Get link code to this page     

Back to Top